ASSOCIATION OF ACCESSIBLE MEDICINES

Lobbying client · District of Columbia · filed 2025 to 2026

Trade Association

$540,000 Reported spend

10 Filings counted

2 Outside firms hired

10 Bills named

Spend is reported income plus in-house expenses across 10 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

Who filed for this client 2

MEHLMAN CONSULTING, INC. $420,000 Outside firm · 7 filings
ENDGAME STRATEGIES, LLC $120,000 Outside firm · 3 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 10

H.R. 3269
ETHIC Act

6 filings
S. 1040
Drug Competition Enhancement Act

6 filings
S. 1954
Biosimilar Red Tape Elimination Act

6 filings
H.R. 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

5 filings
H.R. 5526
Biosimilar Red Tape Elimination Act

5 filings
S. 1302
Increasing Transparency in Generic Drug Applications Act

5 filings
S. 43
Skinny Labels, Big Savings Act

5 filings
H.R. 1262
Mikaela Naylon Give Kids a Chance Act

2 filings
H.R. 9661
Expedited Access to Biosimilars Act

1 filing
S. 1414
Expedited Access to Biosimilars Act

1 filing

Reported by year 2 years

2026 $180,000 3 filings
2025 $360,000 7 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

SENATE 10
HOUSE OF REPRESENTATIVES 7
Health & Human Services, Dept of (HHS) 2
Federal Trade Commission (FTC) 1
Office of Management & Budget (OMB) 1

Recent filings 10 total

Q3 report

MEHLMAN CONSULTING, INC.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026

View → Q2 report

MEHLMAN CONSULTING, INC.

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 17, 2026

View → Q1 report

MEHLMAN CONSULTING, INC.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026

View → Q4 report

MEHLMAN CONSULTING, INC.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026

View → Q3 report

MEHLMAN CONSULTING, INC.

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2025

View → Q3 termination

ENDGAME STRATEGIES, LLC

3rd Quarter 2025 (July 1 - Sep 30) · Senate · $40,000 income · posted Sep 23, 2025

View → Q2 report

ENDGAME STRATEGIES, LLC

2nd Quarter 2025 (Apr 1 - June 30) · Senate · $40,000 income · posted Jul 21, 2025

View → Q2 report

MEHLMAN CONSULTING, INC.

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 21, 2025

View → Q1 report

MEHLMAN CONSULTING, INC.

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 17, 2025

View → Q1 report

ENDGAME STRATEGIES, LLC

1st Quarter 2025 (Jan 1 - Mar 31) · Senate · $40,000 income · posted Apr 15, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.